Rising costs due to fraud, counterfeiting, regulatory changes, not to mention the complexity of globalized supply chains, cost the Life Sciences industry up to $30 billion per year. The constantly changing business environment requires management to make well founded & decisive decisions to ensure competitive advantage and highly accurate, real-time intelligence is essential to respond effectively to changing market dynamics.

CyberCell is able to provide optimized, risk-based Life Sciences solutions designed to provide real-time executive insight and CyberCell research indicates that the typical large pharmaceutical manufacturer can expect to realize significant financial returns through increased risk intelligence and security. Such international intelligence can result in: increased protection for pharmaceutical products; the tightening of the supply chain, thus reduced fraud and counterfeiting: lower liability risk, as well as enhanced ROI on brand and product development, etc.